VACCINEX, INC.

VCNX · OTC · SIC 2834: Pharmaceutical Preparations
143
SEC Filings

Business Summary

1 Item 1A. Risk Factors 45 Item 1B. Unresolved Staff Comments 71 Item 1C. Cybersecurity 71 Item 2. Properties 72 Item 3. Legal Proceedings 72 Item 4. Mine Safety Disclosures 72 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 73 Item 6. Reserved 73 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 74 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 83 Item 8. F...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVCNXdiscussed_in_filing Cybersecurity
topic_mentionVCNXdiscussed_in_filing Cybersecurity
topic_mentionVCNXdiscussed_in_filing Cybersecurity
topic_mentionVCNXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-152024-12-310000950170-25-054318EDGAR90K words
2024-04-022023-12-310000950170-24-039700EDGAR
2023-03-312022-12-310000950170-23-011354EDGAR
2022-03-312021-12-310001564590-22-012778EDGAR
2021-03-312020-12-310001564590-21-016874EDGAR
2020-03-092019-12-310001564590-20-009251EDGAR
2019-03-132018-12-310001564590-19-007458EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2024-11-142024-09-300000950170-24-127139EDGAR27K words
2024-08-142024-06-300000950170-24-097217EDGAR
2024-05-152024-03-310000950170-24-060603EDGAR
2023-11-132023-09-300000950170-23-062454EDGAR
2023-08-142023-06-300000950170-23-042073EDGAR
2023-05-152023-03-310000950170-23-022252EDGAR
2022-11-142022-09-300001564590-22-037499EDGAR
2022-08-152022-06-300001564590-22-029397EDGAR
2022-05-162022-03-310001564590-22-020252EDGAR
2021-11-082021-09-300001564590-21-055065EDGAR
2021-08-162021-06-300001564590-21-044453EDGAR
2021-05-172021-03-310001564590-21-028189EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-03-190001193125-25-057850EDGAR0K words
2025-03-070001193125-25-049988EDGAR
2024-12-170001193125-24-280155EDGAR
2024-11-140001193125-24-258757EDGAR
2024-10-090001193125-24-235251EDGAR
2024-09-190001193125-24-221790EDGAR
2024-09-130001193125-24-218870EDGAR
2024-08-200001193125-24-203149EDGAR
2024-08-140001193125-24-200272EDGAR
2024-07-310001193125-24-189569EDGAR

143 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001205922
TickerVCNX
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0dd9ad48aebce22152915fe89ad5c258954d67b6725625be9541f1a351436c35
parent: 28145a150d2657d6a5755c2744953915d9d72fda25882cf81eb1d5064bcd83ea
content hash: 7dc5783452b91010d81a9ef53d66d2f99d384681e9e0b8da7231cf2e9207efc8
signed: 2026-04-13T04:48:03.601Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf